1. Home
  2. BNKK vs NVNO Comparison

BNKK vs NVNO Comparison

Compare BNKK & NVNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bonk Inc.

BNKK

Bonk Inc.

N/A

Current Price

$2.59

Market Cap

18.9M

ML Signal

N/A

Logo enVVeno Medical Corporation

NVNO

enVVeno Medical Corporation

HOLD

Current Price

$0.32

Market Cap

16.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BNKK
NVNO
Founded
2018
1987
Country
United States
United States
Employees
N/A
N/A
Industry
Package Goods/Cosmetics
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
18.9M
16.7M
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
BNKK
NVNO
Price
$2.59
$0.32
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
325.8K
433.9K
Earning Date
11-19-2025
10-31-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$2,293,124.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
251.44
N/A
52 Week Low
$2.33
$0.30
52 Week High
$46.90
$5.62

Technical Indicators

Market Signals
Indicator
BNKK
NVNO
Relative Strength Index (RSI) N/A 36.69
Support Level N/A $0.32
Resistance Level N/A $0.37
Average True Range (ATR) 0.00 0.03
MACD 0.00 0.01
Stochastic Oscillator 0.00 24.29

Price Performance

Historical Comparison
BNKK
NVNO

About BNKK Bonk Inc.

Bonk Inc is a publicly traded company focused on building a digital asset treasury centered around the BONK ecosystem on the Solana blockchain. It generates revenue through a recurring interest in the memecoin launchpad letsBONK.fun and actively manages its treasury of BONK tokens.

About NVNO enVVeno Medical Corporation

enVVeno Medical Corp is a late clinical-stage medical device company focused on advancing bioprosthetic (tissue-based) solutions to improve the standard of care for treating venous disease. The company's product, VenoValve, is a surgical replacement venous valve that is currently being evaluated in a U.S. pivotal study. The company is also developing a second product called enVVe, which is a non-surgical, transcatheter-based replacement venous valve. Both the products are designed to act as one-way valves to help assist in propelling blood up the veins of the leg, and back to the heart and lungs. The company has determined that it currently operates in a single segment, Medical Device development, located in a single geographic location, the United States.

Share on Social Networks: